Literature DB >> 8377379

CsA, FK506, corticosteroids and rapamycin inhibit TNF alpha production by cultured PTEC.

B A Yard1, R R Pancham, M E Paape, M R Daha, L A van Es, F J van der Woude.   

Abstract

In this study we investigated the effect of immunosuppressive drugs on the interleukin-1 alpha (IL-1 alpha) enhanced tumor necrosis factor alpha (TNF alpha) production by proximal tubular epithelial cells (PTEC). Under basal conditions cultured PTEC produce between 0 to 390 pg/ml/10(5) cells of TNF alpha. Upon stimulation with IL-1 alpha an enhancement of TNF alpha production was seen in each cell line tested, ranging from 230 to 2424 pg/ml/10(5) cells. The presence of cyclosporin A (CsA) during stimulation with IL-1 alpha inhibited the enhanced TNF alpha production in a dose dependent fashion, with a maximal inhibition of 90% at a concentration of 250 ng/ml. Inhibition was at the level of mRNA as could be demonstrated by Northern blot analysis. FK506, corticosteroids and rapamycin also inhibited TNF alpha production in a dose dependent fashion, although not as effectively as CsA. Two corticosteroids were tested for their inhibitory effect on TNF alpha production. It was found that dexamethasone at a concentration of 10 ng/ml inhibited TNF alpha production for almost 40%. A 100-fold higher concentration of hydrocortisone was necessary to yield similar inhibition. The effect of rapamycin on the IL-1 alpha enhanced TNF alpha production differed from the effect of CsA. While CsA induced a maximal inhibition of 90%, rapamycin only induced a maximal inhibition of 37%, and even less inhibition at higher concentrations of the drug. The presence of the various drugs was essential for their inhibitory effect, because removal of the drug from the PTEC by washing immediately resulted in loss of inhibition. Combinations of CsA and FK506 or rapamycin were not additive.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8377379     DOI: 10.1038/ki.1993.251

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  4 in total

1.  Anti-ulcer effect of FK 506, immunosuppressive agent, in rats.

Authors:  A Zeniya; M Otaka; T Kuwabara; S Fujimori; S Otani; O Masamune
Journal:  J Gastroenterol       Date:  1994-06       Impact factor: 7.527

2.  A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.

Authors:  Ellen Kraig; Leslie A Linehan; Hanyu Liang; Terry Q Romo; Qianqian Liu; Yubo Wu; Adriana D Benavides; Tyler J Curiel; Martin A Javors; Nicolas Musi; Laura Chiodo; Wouter Koek; Jonathan A L Gelfond; Dean L Kellogg
Journal:  Exp Gerontol       Date:  2018-02-03       Impact factor: 4.032

3.  Induction of latency-associated peptide (transforming growth factor-β(1)) expression on CD4+ T cells reduces Toll-like receptor 4 ligand-induced tumour necrosis factor-α production in a transforming growth factor-β-dependent manner.

Authors:  Sandra Boswell; Shayan Sharif; Akeel Alisa; Stephen P Pereira; Roger Williams; Shahriar Behboudi
Journal:  Immunology       Date:  2011-03-23       Impact factor: 7.397

4.  Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1β Expression in Primary Mouse Cardiac Fibroblasts.

Authors:  May-Kristin Torp; Kuan Yang; Trine Ranheim; Knut Husø Lauritzen; Katrine Alfsnes; Leif E Vinge; Pål Aukrust; Kåre-Olav Stensløkken; Arne Yndestad; Øystein Sandanger
Journal:  Front Immunol       Date:  2019-06-06       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.